ArticleThe Korean journal of internal medicine2023

Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer.

Soo Han Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.